Cue Biopharma

Cue Biopharma downsizes to focus on autoimmune pipeline
Clinical Trials Arena
Fri, 07/26/24 - 11:09 am
Cue Biopharma
autoimmune disease
layoffs
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Cue's IL-2-based Biologic Shows Early Promise in Head and Neck Cancer
BioSpace
Sun, 11/13/22 - 07:06 pm
Cue Biopharma
CUE-101
head and neck cancer
An In-Depth Look at Innovation on Cancer Research Day
BioSpace
Sun, 09/26/21 - 11:24 pm
cancer
oncology
R&D
Cue Biopharma
Celyad Oncology
Fore Biotherapeutics
X4 Pharmaceuticals
Elicio Therapeutics
OSE Immunotherapeutics
Sotio
GigaGen
3 Biotech Start-Ups That Could Soar in 2020
Motley Fool
Mon, 01/27/20 - 10:50 am
Cue Biopharma
Rubius Therapeutics
CRISPR Therapeutics
Nasdaq Exec 'Even More Bullish' On Biotech IPOs As New Entries Soar
Forbes
Tue, 01/30/18 - 09:28 am
biotech
NASDAQ
IPOs
ARMO BioSciences
Menlo Therapeutics
Cue Biopharma
Merck strikes autoimmune deal with newly-emerged Cue
BioPharma Dive
Fri, 11/17/17 - 10:18 am
Merck
autoimmune disease
Cue Biopharma
R&D
drug development